Synthesis, QSAR and anti-HIV activity of new 5-benzylthio-1,3,4-oxadiazoles derived from α-amino acids

References

• Hijikata M, Ohta Y, Baba K. Iwata K, Matsumoto M, Mishiro S, Kanai K. Instability of the NS5A ISDR of hepatitis C virus during natural course: take-over of wild type by mutant type or vice-versa driven by immune pressure. Hepatology Res 1998;11:19–25.
   Google Scholar
• Bartenschlager R, Lohmann V. Novel cell culture systems for the hepatitis C virus. Antiviral Res 2001;52:1–17.
   PubMedGoogle Scholar
• Zareef M, Iqbal R, Al-Masoudi NA, Zaidi JH, Arfan M, Shahzad SA. Synthesis, anti-HIV and antifungal activity of new benzensulphonamides bearing 2,5-disubstituted 1,3,4-oxadiazole moiety. Phosphorus Sulfur Silicon Relat Elem 2007;182:281–298.
   Web of Science ®Google Scholar
• Iqbal R, Zareef M, Ahmed S, Zaidi JH, Arfan M, Shafique M, Al-Masoudi NA. Synthesis, antimicrobial and anti-HIV activity of some novel benzenesulfonamides bearing 2,5-disubstituted-1,3,4-oxadiazole moiety. J Chin Chem Soc 2006;53:689–696.
   Web of Science ®Google Scholar
• El-Emam AA, Al-Deeb OA, Al-Omar M, Lehmann J. Synthesis, antimicrobial, and anti-HIV-1 activity of certain 5-(1-adamantyl)-2-substituted thio-1,3,4-oxadiazoles and 5-(1-adamantyl)-3-substituted aminomethyl-1,3,4-oxadiazoline-2-thiones. Bioorg Med Chem 2004;12:5107–5113.
   PubMed Web of Science ®Google Scholar
• Johns BA, Weatherhead JG, H. Allen, SH, Thompson JB, Garvey EP, Foster SA, Jeffrey JL, Miller WH. The use of oxadiazole and triazole substituted naphthyridines as HIV-1 integrase inhibitors. Part 1: Establishing the pharmacophore. Bioorg Med Chem Lett 2009;19:1802–1806.
   PubMed Web of Science ®Google Scholar
• Lennox JL, DeJesus E, Lazzarin A, Pollard RB, Madruga JV, Berger DS et al.; STARTMRK investigators. Safety and efficacy of raltegravir-based versus efavirenz-based combination therapy in treatment-naive patients with HIV-1 infection: a multicentre, double-blind randomised controlled trial. Lancet 2009;374:796–806.
   PubMed Web of Science ®Google Scholar
• Yan S, Appleby T, Larson G, Wu JZ, Hamatake RK, Hong Z et al. Thiazolone-acylsulfonamides as novel HCV NS5B polymerase allosteric inhibitors: convergence of structure-based drug design and X-ray crystallographic study. Bioorg Med Chem Lett 2007;17:1991–1995.
   PubMedGoogle Scholar
• Yannopoulos CG, Xu P, Ni F, Chan L, Pereira OZ, Reddy TJ et al. HCV NS5B polymerase-bound conformation of a soluble sulfonamide inhibitor by 2D transferred NOESY. Bioorg Med Chem Lett 2004;14:5333–5337.
   PubMedGoogle Scholar
• Selvam P, Murugesh N, Chandramohan M, Sidwell RW, Wandersee MK, Smee DF. Anti-influenza virus activities of 4-[(1,2-dihydro-2-oxo-3H-indol-3-ylidene)amino]-N-(4,6-dimethyl-2-pyrimidin-2-yl)benzenesulphonamide and its derivatives. Antiviral Chem Chemother 2006;17:269–274.
   PubMedGoogle Scholar
• Li X, Yang X, Liang X, Kai Z, Yuan H, Yuan D, Zhang J, Wang R, Ran F, Qi S, Ling Y, Chen F, Wang D. Synthesis and biological activities of 2-oxocycloalkylsulfonamides Bioorg Med Chem 2008;16:4538–4544.
   PubMedGoogle Scholar
• Vermeire K, Schols D. Cyclotriazadisulfonamides: promising new CD4-targeted anti-HIV drugs. J Antimicrob Chemother 2005;56:270–272.
   PubMedGoogle Scholar
• Akhtar T, Hameed S, Al-Masoudi NA, Loddo R, La Colla P. In vitro antitumor and antiviral activities of new benzothiazole and 1,3,4-oxadiazole-2-thione. Acta Pharm 2008;58:135–149.
   PubMed Web of Science ®Google Scholar
• Akhtar T, Hameed S, Al-Masoudi NA, Khan KM. Synthesis, and anti-HIV activity of new chiral 1,2,4-triazoles and 1,3,4-thiadiazoles. Heteroatom Chem 2007;18:316–322.
   Web of Science ®Google Scholar
• Zahid M, Yasin KA, Akhtar T, Rama NH, Hameed S, Al-Masoudi NA., Loddo R, La Colla P. New 2-(4-aryl)-5-(2-adamantylthiazol-4-yl)-1,3,4-oxadiazoles as potential antiproliferative and antiviral agents, ARKIVOC 2009;xi: 85–93.
   Google Scholar
• Serwar M, Akhtar T, Hameed S, Khan KM. Synthesis, urease inhibition and antimicrobial activities of some chiral 5-aryl-4-(1-phenylpropyl)-2H-1,2,4-triazole-3-(4H)-thione. ARKIVOC 2009;vii:210–221.
   Google Scholar
• Akhtar T, Hameed S, Khan KM, Choudhary MI. Syntheses, urease inhibition, and antimicrobial studies of some chiral 3-substituted-4-amino-5-thioxo-1H,4H-1,2,4-triazoles. Med Chem 2008;4:539–543.
   PubMed Web of Science ®Google Scholar
• Stewart JJP. Optimization of parameters for semi-empirical methods. I Method J Comput Chem 1989;10:209–220.
   Web of Science ®Google Scholar
• Sheldrick GMA. Short history of SHELX. Acta Cryst 2008;A64:112–122.
   Google Scholar
• Zareef M, Iqbal R, De Dominguez NG, Rodrigues J, Zaidi JH, Arfan M, Supuran CT. Synthesis andantimalarial activity of novel chiral and achiral benzenesulfonamides bearing 1, 3, 4-oxadiazole moieties. J Enz Inhib Med Chem 2007;22:301–308.
   PubMed Web of Science ®Google Scholar
• Zarghi A, Faizi M, Shafaghi B, Ahadian A, Khojastehpoor HR, Zanganeh V et al. Design and synthesis of new 2-substituted-5-(2-benzylthiophenyl)-1,3,4-oxadiazoles as benzodiazepine receptor agonists. Bioorg Med Chem Lett 2005;15:3126–3129.
   PubMedGoogle Scholar
• Koparir M, Cetin A, Cansiz A. 5-Furan-2-yl[1,3,4]oxadiazole-2-thiol, 5-furan-2yl-4H [1,2,4] triazole-3-thiol and their thiol-thione tautomerism. Molecules 2005;10:475–480.
   PubMed Web of Science ®Google Scholar
• Hargrave KD, Proudfoot JR, Grozinger KG, Cullen E, Kapadia SR, Patel UR et al. Novel non-nucleoside inhibitors of HIV-1 reverse transcriptase. 1. Tricyclic pyridobenzo- and dipyridodiazepinones. J Med Chem 1991;34:2231–2241.
   PubMed Web of Science ®Google Scholar
• Mitsuya H, Weinhold KJ, Furman PA, St Clair MH, Lehrman SN, Gallo RC et al. 3′-Azido-3′-deoxythymidine (BW A509U): an antiviral agent that inhibits the infectivity and cytopathic effect of human T-lymphotropic virus type III/lymphadenopathy-associated virus in vitro. Proc Natl Acad Sci USA 1985;82:7096–7100.
   PubMed Web of Science ®Google Scholar
• Fletcher P. Practical Methods of Optimization. New York: Wiley, 1990.
   Google Scholar
• Rui OM, Qian L. I. 2D-QSAR studies on phenoxybenzoic acid derivatives: A novel class of 5α -reductase inhibitors. Chinese J Struct Chem 2008; 27: 105–111.
   Google Scholar